New diabetes clinical trial: Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Published on: March 27, 2025 at 11:00PM
Conditions: Proliferative Diabetic Retinopathy - High Risk
Interventions: Procedure: Bevacizumab
Sponsors: Christian Ophthalmic Surgery Expedition Network
Recruiting
https://ift.tt/HwKJtLp
Conditions: Proliferative Diabetic Retinopathy - High Risk
Interventions: Procedure: Bevacizumab
Sponsors: Christian Ophthalmic Surgery Expedition Network
Recruiting
https://ift.tt/HwKJtLp
Comments
Post a Comment